PMGC Holdings Inc. (ELAB) NASDAQ
4.58
+0.18(+4.09%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
4.58
+0.18(+4.09%)
Currency In USD
Address
120 Newport Center Drive
Newport Beach, CA 92660
United States of America (the)
Phone
866 445 4886
Website
Sector
Healthcare
Industry
Biotechnology
Employees
2
First IPO Date
November 21, 2023
| Name | Title | Pay | Year Born |
| Graydon Bensler | Chief Executive Officer, Chief Financial Officer, Secretary & Director | 391,333 | 1991 |
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operates investment firms. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.